Genetic variants in IRF5 and IRF7 associated with SLE susceptibility are considered gain-of-function variants and are related to increased serum IFN-α levels in SLE patients with specific autoantibodies [27,45]. Here, IFNA1 is linked to systemic lupus erythematosus.